Literature DB >> 16272322

The extent of histone acetylation correlates with the differential rearrangement frequency of individual VH genes in pro-B cells.

Celia R Espinoza1, Ann J Feeney.   

Abstract

During B lymphocyte development, Ig heavy and L chain genes are assembled by V(D)J recombination. Individual V, D, and J genes rearrange at very different frequencies in vivo, and the natural variation in recombination signal sequence does not account for all of these differences. Because a permissive chromatin structure is necessary for the accessibility of VH genes for VH to DJH recombination, we hypothesized that gene rearrangement frequency might be influenced by the extent of histone modifications. Indeed, we found in freshly isolated pro-B cells from muMT mice a positive correlation between the level of enrichment of VHS107 genes in the acetylated histone fractions as assayed by chromatin immunoprecipitation, and their relative rearrangement frequency in vivo. In the VH7183 family, the very frequently rearranging VH81X gene showed the highest association with acetylated histones, especially in the newborn. Together, our data show that the extent of histone modifications in pro-B cells should be considered as a mechanism by which accessibility and the rearrangement level of individual VH genes is regulated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16272322     DOI: 10.4049/jimmunol.175.10.6668

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Determinants of public T cell responses.

Authors:  Hanjie Li; Congting Ye; Guoli Ji; Jiahuai Han
Journal:  Cell Res       Date:  2012-01-03       Impact factor: 25.617

2.  Chromatin accessibility and epigenetic modifications differ between frequently and infrequently rearranging VH genes.

Authors:  Celia R Espinoza; Ann J Feeney
Journal:  Mol Immunol       Date:  2007-01-10       Impact factor: 4.407

Review 3.  Epigenetic aspects of lymphocyte antigen receptor gene rearrangement or 'when stochasticity completes randomness'.

Authors:  Sébastien Jaeger; Bastien Fernandez; Pierre Ferrier
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

Review 4.  Epigenetic and 3-dimensional regulation of V(D)J rearrangement of immunoglobulin genes.

Authors:  Stephanie C Degner-Leisso; Ann J Feeney
Journal:  Semin Immunol       Date:  2010-09-15       Impact factor: 11.130

5.  Reciprocal patterns of methylation of H3K36 and H3K27 on proximal vs. distal IgVH genes are modulated by IL-7 and Pax5.

Authors:  Cheng-Ran Xu; Lana Schaffer; Steven R Head; Ann J Feeney
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-17       Impact factor: 11.205

6.  Cutting edge: developmental stage-specific recruitment of cohesin to CTCF sites throughout immunoglobulin loci during B lymphocyte development.

Authors:  Stephanie C Degner; Timothy P Wong; Gytis Jankevicius; Ann J Feeney
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

7.  Deep sequencing of the murine IgH repertoire reveals complex regulation of nonrandom V gene rearrangement frequencies.

Authors:  Nancy M Choi; Salvatore Loguercio; Jiyoti Verma-Gaur; Stephanie C Degner; Ali Torkamani; Andrew I Su; Eugene M Oltz; Maxim Artyomov; Ann J Feeney
Journal:  J Immunol       Date:  2013-07-29       Impact factor: 5.422

8.  The epigenetic profile of Ig genes is dynamically regulated during B cell differentiation and is modulated by pre-B cell receptor signaling.

Authors:  Cheng-Ran Xu; Ann J Feeney
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

9.  Glucose-stimulated expression of Txnip is mediated by carbohydrate response element-binding protein, p300, and histone H4 acetylation in pancreatic beta cells.

Authors:  Hyunjoo Cha-Molstad; Geetu Saxena; Junqin Chen; Anath Shalev
Journal:  J Biol Chem       Date:  2009-05-01       Impact factor: 5.157

Review 10.  Chronic lymphocytic leukaemia: could immunological tolerance mechanisms be the origin of lymphoid neoplasms?

Authors:  Ricardo García-Muñoz; Luis Llorente
Journal:  Immunology       Date:  2014-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.